TTK and neoplasm: Next, we performed an integrated analysis to evaluate differences in the TIME (e.g., the abundance of tumor-infiltrating cells, molecular markers of immune cells, and immunomodulatory gene expression) and metabolic features (e.g., glycolipid metabolism) between the TTK subtypes.